Jiangsu Nhwa Pharmaceutical Co Ltd
SZSE:002262
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
21.36
28.12
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jiangsu Nhwa Pharmaceutical Co Ltd
Gross Margin
Jiangsu Nhwa Pharmaceutical Co Ltd
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | CN |
| Market Cap | 27.1B CNY |
| Gross Margin |
71%
|
| Country | JP |
| Market Cap | 776 550.9T JPY |
| Gross Margin |
-3%
|
| Country | US |
| Market Cap | 749.7B USD |
| Gross Margin |
81%
|
| Country | UK |
| Market Cap | 440.4B GBP |
| Gross Margin |
56%
|
| Country | DK |
| Market Cap | 3.4T DKK |
| Gross Margin |
85%
|
| Country | US |
| Market Cap | 372B USD |
| Gross Margin |
69%
|
| Country | US |
| Market Cap | 257.3B USD |
| Gross Margin |
77%
|
| Country | CH |
| Market Cap | 200.4B CHF |
| Gross Margin |
73%
|
| Country | UK |
| Market Cap | 162.7B GBP |
| Gross Margin |
82%
|
| Country | CH |
| Market Cap | 179.9B CHF |
| Gross Margin |
75%
|
| Country | IE |
| Market Cap | 146B USD |
| Gross Margin |
68%
|
Jiangsu Nhwa Pharmaceutical Co Ltd
Glance View
Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the pharmaceutical production, research and development, and sales. The company is headquartered in Xuzhou, Jiangsu and currently employs 4,732 full-time employees. The company went IPO on 2008-07-23. The firm offers its pharmaceutical products under four categories, which consist of anesthetic medicines, including midazolam injections and etomidate fat emulsion pharmaceutical preparations injections; psychiatric medicines, including risperidone tablets and others; neurological medicines, including gabapentin capsules and others; bulk drugs, including fenofibrate and miconazole nitrate. The firm is also engaged in the pharmaceuticals trading business. Through its subsidiaries, the Company is also engaged in the Internet medical businesses. The firm distributes its products within domestic market and to overseas markets.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Jiangsu Nhwa Pharmaceutical Co Ltd's most recent financial statements, the company has Gross Margin of 70.9%.
You don't have any saved screeners yet
